Burning Rock Biotech Current Cash

Burning Rock Biotech (BNR) currently reports a current cash of $450M as of March 2026. That compares with $500M in the prior-year period — down 9.9% year over year. Use the charts on this page to explore Burning Rock Biotech's current cash history and peer comparisons.

Burning Rock Biotech's current cash decreased from $500M to $450M — a 9.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Burning Rock Biotech reported $450M in current cash as of March 2026. That compares with $500M in the prior-year period — down 9.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $450M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Burning Rock Biotech, and consider following BNR for alerts when major investors trade the stock.

Burning Rock Biotech is classified in the Healthcare sector. On current cash, it currently shows $450M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNR with unrelated industries.